Optimizing Cost-Effective Care for Chronic Constipation in General Gastroenterology Using an Office-Based, Point-Of-Care Test (RED): Cost-Effectiveness and Cost-Minimization Analysis.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 39167526.
- Also identified by DOI 10.14309/ajg.0000000000002989 and PMC identifier 11617264.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We aimed to evaluate the cost-effectiveness/cost-savings of point-of-care anorectal function testing with an investigational device (RED) to triage therapy for chronic constipation in general gastroenterology. A Markov model was constructed to evaluate cost-effectiveness/cost-savings over a 1-year time horizon comparing empiric drug/pelvic floor physical therapy to testing guided care. RED appears to inform the cost-effective strategy for chronic constipation. Compared with usual care without RED, it reduces insurer costs by $810 and patient costs by $6,903. Point-of-care testing using RED appears cost-effective/cost-saving to triage chronic constipation care in general gastroenterology.
Medical subject headings
- Constipation
- Cost-Benefit Analysis
- Markov Chains